INS and type 2 diabetes mellitus: A patient-level meta-analysis of the EDITION 1, 2, and 3 trials compared the efficacy and safety of Glar-300 and Glar-100 in people with T2DM as related to basal and mealtime insulin, basal insulin and oral antihyperglycemic drugs, or no prior insulin, respectively.